glp 1 receptor agonists incretin mimetics GLP1 Agonists—Effects beyond Obesity and Diabetes Frontiers | GLP−1 receptor agonists

2 In addition to lifestyle modifications (diet and exercise), many pharmacologic strategies have been proposed to counter iatrogenic weight gain, including appetite suppressants (eg, pro-dopaminergic agents such as phentermine, stimulants, and amantadine), pro-anorectant anticonvulsants (eg, topiramate or zonisamide), opioid receptor antagonists (eg, olanzapine/samidorphan or naltrexone) and oral hypoglycemics such as metformin

Curry is known for his experience in minimally invasive bariatric surgery, his leadership in outpatient weight loss surgery, and his commitment to helping patients choose the treatment option that best fits their medical needs and long-term goals

However, the Bridge program will pay for these drugs only when used specifically for weight loss

Intranasal Delivery of Exendin-4 Confers Neuroprotective Effect Against Cerebral Ischemia in Mice